var data={"title":"Acetaminophen (paracetamol): Drug information","body":"<div id=\"topicContent\" class=\"utdArticleSection utdStyle\"><div id=\"drugTitle\">Acetaminophen (paracetamol): Drug information</div><div id=\"lexiTitleImg\"></div><div class=\"clear\"></div><div id=\"lcoSearchClickUrl\"><a href=\"http://online.lexi.com/lco/action/api/find/globalid/5549?utd=1\" target=\"_blank\">Access Lexicomp Online here.</a></div><div id=\"drugCopy\">Copyright 1978-2018 Lexicomp, Inc. All rights reserved.</div><div id=\"topicText\">(For additional information <a href=\"topic.htm?path=acetaminophen-paracetamol-patient-drug-information\" class=\"drug drug_patient\">see &quot;Acetaminophen (paracetamol): Patient drug information&quot;</a> and <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Acetaminophen (paracetamol): Pediatric drug information&quot;</a>)<br></br>For abbreviations and symbols that may be used in Lexicomp (<a href=\"image.htm?imageKey=DRUG%2F57469\" class=\"graphic graphic_table\">show table</a>)<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F22782418\" class=\"block black-box-warn drugH1Div\"><span class=\"drugH1\">ALERT: US Boxed Warning</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Risk of medication errors and hepatotoxicity (injection):</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:2em;\">Take care when prescribing, preparing, and administering acetaminophen injection to avoid dosing errors that could result in accidental overdose and death. In particular, be careful to ensure the following: the dose in milligrams and milliliters is not confused; the dosing is based on weight for patients less than 50 kg; infusion pumps are properly programmed; and the total daily dose of acetaminophen from all sources does not exceed maximum daily limits.</p>\n        <p style=\"text-indent:-2em;margin-left:2em;\">Acetaminophen has been associated with cases of acute liver failure, at times resulting in liver transplant and death. Most of the cases of liver injury are associated with the use of acetaminophen at doses that exceed the maximum daily limits, and often involve more than 1 acetaminophen-containing product.</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129318\" class=\"list ubnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: US</span>\n    <ul>\n      <li>Acephen [OTC];</li>\n      <li>Aspirin Free Anacin Extra Strength [OTC];</li>\n      <li>Cetafen Extra [OTC];</li>\n      <li>Cetafen [OTC];</li>\n      <li>FeverAll Adult [OTC];</li>\n      <li>FeverAll Children's [OTC];</li>\n      <li>FeverAll Infants' [OTC];</li>\n      <li>FeverAll Junior Strength [OTC];</li>\n      <li>Little Fevers [OTC];</li>\n      <li>Mapap Arthritis Pain [OTC];</li>\n      <li>Mapap Children's [OTC];</li>\n      <li>Mapap Extra Strength [OTC];</li>\n      <li>Mapap Infants' [OTC] [DSC];</li>\n      <li>Mapap [OTC];</li>\n      <li>Midol Long Lasting Relief [OTC];</li>\n      <li>Non-Aspirin Pain Reliever [OTC];</li>\n      <li>Nortemp Children's [OTC];</li>\n      <li>Ofirmev;</li>\n      <li>Pain &amp; Fever Children's [OTC];</li>\n      <li>Pain Eze [OTC];</li>\n      <li>Pharbetol Extra Strength [OTC];</li>\n      <li>Pharbetol [OTC];</li>\n      <li>Q-Pap Children's [OTC] [DSC];</li>\n      <li>Q-Pap Extra Strength [OTC] [DSC];</li>\n      <li>Q-Pap Infants' [OTC] [DSC];</li>\n      <li>Q-Pap [OTC] [DSC];</li>\n      <li>Silapap Children's [OTC];</li>\n      <li>Silapap Infants' [OTC] [DSC];</li>\n      <li>Triaminic Children's Fever Reducer Pain Reliever [OTC];</li>\n      <li>Tylenol 8 HR Arthritis Pain [OTC];</li>\n      <li>Tylenol 8 HR [OTC] [DSC];</li>\n      <li>Tylenol Children's [OTC];</li>\n      <li>Tylenol Extra Strength [OTC];</li>\n      <li>Tylenol Infants' [OTC];</li>\n      <li>Tylenol Jr. Meltaways [OTC] [DSC];</li>\n      <li>Tylenol [OTC];</li>\n      <li>Valorin Extra [OTC];</li>\n      <li>Valorin [OTC]</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129319\" class=\"list cbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: Canada</span>\n    <ul>\n      <li>Abenol;</li>\n      <li>Apo-Acetaminophen;</li>\n      <li>Atasol;</li>\n      <li>Novo-Gesic;</li>\n      <li>Pediatrix;</li>\n      <li>Tempra;</li>\n      <li>Tylenol</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129370\" class=\"ex_sect_xr thclist drugH1Div drugBrandNames\"><span class=\"drugH1\">Pharmacologic Category</span>\n    <ul>\n      <li>\n        Analgesic, Nonopioid</li></ul></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129323\" class=\"block doa drugH1Div\"><span class=\"drugH1\">Dosing: Adult</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> In 2011, McNeil Consumer Healthcare reduced the maximum doses and increased the dosing interval on the labeling of some of their acetaminophen OTC products used in older pediatric patients (usually children &ge; 12 years and adolescents) and adults in an attempt to protect consumers from inadvertent overdoses. For example, the maximum daily dose of Tylenol  Extra Strength and Tylenol Regular Strength was decreased and the dosing interval for Tylenol Extra Strength was increased. Health care professionals may still prescribe or recommend the 4 g daily maximum to patients (but are advised to use their own discretion and clinical judgment) (McNeil Consumer Healthcare, 2014).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Pain or fever:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Oral: </i> <b>Note:</b> OTC dosing recommendations may vary by product and/or manufacturer. When calculating the maximum daily dose, consider all sources of acetaminophen (prescription and OTC) and all routes of administration. Do not exceed the maximum recommended daily dose. No dose adjustment required when converting between different acetaminophen formulations.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Immediate-release:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Regular strength: 650 mg every 4 to 6 hours; maximum daily dose: 3250 mg <b>daily</b> unless directed by health care provider; under health care provider supervision, daily doses &le;4 g may be used</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Extra strength: 1000 mg every 6 hours; maximum daily dose: 3000 mg <b>daily</b> unless directed by a health care provider; under health care provider supervision, daily doses &le;4 g may be used</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Extended-release: 1300 mg every 8 hours; maximum daily dose: 3900 mg <b>daily </b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Rectal:</i> 650 mg every 4 to 6 hours; maximum daily dose: 3900 mg <b>daily</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>IV:</i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&lt;50 kg: 12.5 mg/kg every 4 hours or 15 mg/kg every 6 hours; maximum single dose: 15 mg/kg/dose (&le;750 mg/dose); maximum daily dose: 75 mg/kg/day (&le;3.75 g/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&ge;50 kg: 650 mg every 4 hours or 1,000 mg every 6 hours; maximum single dose: 1,000 mg/dose; maximum daily dose: 4 g/day</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129345\" class=\"block dop drugH1Div\"><span class=\"drugH1\">Dosing: Pediatric</span><p>(For additional information <a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">see &quot;Acetaminophen (paracetamol): Pediatric drug information&quot;</a>)</p>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Note:</b> In 2011, McNeil Consumer Healthcare reduced the maximum doses and increased the dosing interval on the labeling of some of their acetaminophen OTC products used in older pediatric patients (usually children &ge;12 years and adolescents) in an attempt to protect consumers from inadvertent overdoses. For example, the maximum daily dose of Tylenol Extra Strength OTC and Tylenol Regular Strength OTC was decreased and the dosing interval for Tylenol Extra Strength OTC was increased. Health care professionals may still prescribe or recommend the 4 g daily maximum to patients (but are advised to use their own discretion and clinical judgment) (McNeil Consumer Healthcare, 2014).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <b>Pain or fever:</b></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <i>Oral: </i> <b>Note:</b> When calculating the maximum daily dose, consider all sources of acetaminophen (prescription and OTC) and all routes of administration. Do not exceed the maximum recommended daily dose (see dosing information for further detail).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Weight-based dosing: Infants, Children, and Adolescents: 10 to 15 mg/kg/dose every 4 to 6 hours as needed (APS, 2008; Sullivan, 2011); do <b>not</b> exceed 5 doses in 24 hours; maximum daily dose: 75 mg/kg/day not to exceed 4 g daily.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Fixed dosing: Oral suspension, chewable tablets: Infants and Children &lt;12 years: Consult specific product formulations for appropriate age groups. See table; use of weight to select dose is preferred; if weight is not available, then use age; doses may be repeated every 4 hours; maximum: 5 doses daily.</p>\n    <table border=\"1\" rules=\"all\" frame=\"border\">\n      <caption style=\"text-align:center;\">Acetaminophen Pediatric Dosing (Oral)<sup>1</sup></caption>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <col align=\"center\"></col>\n      <thead valign=\"middle\">\n        <tr>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Weight (kg)</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Weight</p>\n            <p style=\"text-indent:0em;\">(lbs)</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Age</p></th>\n          <th align=\"center\">\n            <p style=\"text-indent:0em;\">Dosage</p>\n            <p style=\"text-indent:0em;\">(mg)</p></th></tr></thead>\n      <tfoot valign=\"middle\">\n        <tr>\n          <td colspan=\"4\" align=\"left\">\n            <p style=\"text-indent:0em;\">\n              <sup>1</sup>Manufacturer&rsquo;s recommendations are based on weight in pounds (OTC labeling); weight in kg listed here is derived from pounds and rounded; kg weight listed also is adjusted to allow for continuous weight ranges in kg. OTC labeling instructs consumer to consult with health care provider for dosing instructions in infants and children under 2 years of age.</p></td></tr></tfoot>\n      <tbody valign=\"middle\">\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">2.7-5.3</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">6-11</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">0-3 mo</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">40</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">5.4-8.1</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">12-17</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">4-11 mo</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">80</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">8.2-10.8</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">18-23</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">1-2 y</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">120</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">10.9-16.3</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">24-35</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">2-3 y</p></td>\n          <td valign=\"middle\" align=\"center\">\n            <p style=\"text-indent:0em;\">160</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">16.4-21.7</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">36-47</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">4-5 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">240</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">21.8-27.2</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">48-59</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">6-8 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">320</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">27.3-32.6</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">60-71</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">9-10 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">400</p></td></tr>\n        <tr>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">32.7-43.2</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">72-95</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">11 y</p></td>\n          <td align=\"center\">\n            <p style=\"text-indent:0em;\">480</p></td></tr></tbody></table>\n    \n    <p style=\"text-indent:-2em;margin-left:4em;\">Immediate release solid dosage formulations: <b>Note:</b> Actual OTC dosing recommendations may vary by product and/or manufacturer:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children 6 to 11 years: 325 mg every 4 to 6 hours; maximum daily dose: 1625 mg <b>daily</b>; <b>Note:</b> Do not use for more than 5 days unless directed by a health care provider</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Extended release: Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <i>Rectal: </i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants 6 to 11 months: 80 mg every 6 hours; maximum daily dose: 320 mg <b>daily</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants and Children 12 to 36 months: 80 mg every 4 to 6 hours; maximum daily dose: 400 mg <b>daily</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;3 to 6 years: 120 mg every 4 to 6 hours; maximum daily dose: 600 mg <b>daily</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &gt;6 up to 12 years: 325 mg every 4 to 6 hours; maximum daily dose: 1625 mg <b>daily</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children &ge;12 years and Adolescents: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">\n      <i>IV:</i></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Neonates (including premature neonates born &ge;32 weeks gestational age) up to 28 days (fever only): 12.5 mg/kg every 6 hours; maximum daily dose: 50 mg/kg/day.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants 29 days to 2 years of age (fever only): 15 mg/kg every 6 hours; maximum daily dose: 60 mg/kg/day.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Children 2 to 12 years: 12.5 mg/kg every 4 hours or 15 mg/kg every 6 hours; maximum single dose: 15 mg/kg/dose (&le;750 mg/dose); maximum daily dose: 75 mg/kg/day (&le;3.75 g/day)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adolescents: Refer to adult dosing.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129324\" class=\"block doe drugH1Div\"><span class=\"drugH1\">Dosing: Geriatric</span>\n    <p style=\"text-indent:-2em;margin-left:2em;display:inline\">\n      <b>Pain (acute) or fever:</b> Oral, IV: Refer to adult dosing.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Persistent pain (off-label):</b> Adults &ge;75 years: Oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Initial:</i> 325 to 500 mg every 4 hours or 500 to 1,000 mg every 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">\n      <i>Maximum:</i> &le;4,000 mg/day. In older adults with hepatic impairment or history of alcohol abuse being treated for persistent pain, do not exceed a maximum of 2,000 to 3,000 mg/day (AGS 2009)</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129325\" class=\"block dor drugH1Div\"><span class=\"drugH1\">Dosing: Renal Impairment</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral (Aronoff 2007):</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GFR &ge;50 mL/minute: No dosage adjustment necessary.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GFR 10 to 50 mL/minute: Administer every 6 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GFR &lt;10 mL/minute: Administer every 8 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">CRRT: Administer every 6 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Infants, Children, and Adolescents:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GFR &ge;10 mL/minute/1.73 m<sup>2</sup>: No dosage adjustment necessary.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">GFR &lt;10 mL/minute/1.73 m<sup>2</sup>: Administer every 8 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Intermittent hemodialysis or peritoneal dialysis: Administer every 8 hours.</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">CRRT: No dosage adjustment necessary.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">IV: Children, Adolescents, and Adults:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">CrCl &gt;30 mL/minute: There are no dosage adjustments provided in the manufacturer's labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">CrCl &le;30 mL/minute: There are no dosage adjustments provided in the manufacturer's labeling. Use with caution; consider decreasing daily dose and extending dosing interval.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129326\" class=\"block doh drugH1Div\"><span class=\"drugH1\">Dosing: Hepatic Impairment</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral: Use with extreme caution. Although limited data exist, low-dose (&le;2 to 3 g/day) therapy is usually well tolerated in hepatic disease/cirrhosis; however, factors such as alcohol use, nutritional status, and renal function must also be taken into consideration (Bosilkovska 2012; Chandok 2010; Dwyer 2014; Hayward 2015, Imani 2014). In patients with hepatic impairment/cirrhosis and active alcohol use, most experts recommend avoiding use as much as possible, and if used, limiting therapy to short-term use only at doses &le;2 g/day (Bosilkovska 2012; Chandok 2010).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">IV:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mild to moderate impairment: There are no dosage adjustments provided in the manufacturer's labeling. Use with caution; a reduced total daily dosage may be warranted.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Severe impairment: Use is contraindicated.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129293\" class=\"block foc drugH1Div\"><span class=\"drugH1\">Dosage Forms</span>\n    <p style=\"text-indent:0em;display:inline\">Excipient information presented when available (limited, particularly for generics); consult specific product labeling. [DSC] = Discontinued product</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Caplet, oral: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cetafen Extra: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg [scored]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain Eze: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Caplet, extended release, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Arthritis Pain: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Midol Long Lasting Relief: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol 8 HR Arthritis Pain: 650 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Capsule, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection, solution [preservative free]:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Ofirmev: 10 mg/mL (100 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Liquid, oral: 160 mg/5 mL (120 mL, 473 mL); 500 mg/5 mL (240 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg/5 mL (237 mL) [contains propylene glycol, sodium 9 mg/15 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Children's: 160 mg/5 mL (118 mL [DSC], 473 mL [DSC]) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; cherry flavor, grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silapap Children's: 160 mg/5 mL (118 mL, 237 mL, 473 mL) [ethanol free, sugar free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg/15 mL (240 mL [DSC]) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, oral: 160 mg/5 mL (5 mL, 10 mL, 20 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain &amp; Fever Children's: 160 mg/5 mL (118 mL, 473 mL) [ethanol free, sugar free; contains propylene glycol, sodium 1 mg/5 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Solution, oral [drops]: 80 mg/0.8 mL (15 mL [DSC])</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Little Fevers: 80 mg/mL (30 mL [DSC]) [dye free, ethanol free, gluten free; contains propylene glycol, sodium benzoate; berry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Infants': 80 mg/0.8 mL (15 mL [DSC]) [ethanol free; contains propylene glycol; fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Silapap Infants': 80 mg/0.8 mL (15 mL [DSC], 30 mL [DSC]) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suppository, rectal: 120 mg (12s); 325 mg (12s); 650 mg (12s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Acephen: 120 mg (12s, 50s, 100s); 325 mg (6s, 12s, 50s, 100s); 650 mg (12s, 50s, 100s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Adults: 650 mg (50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Children's: 120 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Infants': 80 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">FeverAll Junior Strength: 325 mg (6s, 50s)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Suspension, oral: 160 mg/5 mL (5 mL, 10.15 mL, 20.3 mL)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 160 mg/5 mL (118 mL) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Infants': 160 mg/5 mL (59 mL [DSC]) [dye free, ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Nortemp Children's: 160 mg/5 mL (118 mL) [ethanol free; contains propylene glycol, sodium benzoate; cotton candy flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pain &amp; Fever Children's: 160 mg/5 mL (60 mL) [ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Children's: 160 mg/5 mL (118 mL [DSC]) [ethanol free; contains sodium 2 mg/5 mL, sodium benzoate; bubblegum flavor, cherry flavor, grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [dye free, ethanol free; contains propylene glycol, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (60 mL, 120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; cherry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Children's: 160 mg/5 mL (120 mL) [ethanol free; contains propylene glycol, sodium 2 mg/5 mL, sodium benzoate; strawberry flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Infants': 160 mg/5 mL (60 mL) [ethanol free; contains propylene glycol, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Syrup, oral:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Children's Fever Reducer Pain Reliever: 160 mg/5 mL (118 mL) [contains benzoic acid, sodium 6 mg/5 mL; bubblegum flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Triaminic Children's Fever Reducer Pain Reliever: 160 mg/5 mL (118 mL) [contains sodium 5 mg/5 mL, sodium benzoate; grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, oral: 325 mg, 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Aspirin Free Anacin Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Cetafen: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Non-Aspirin Pain Reliever: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pharbetol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Pharbetol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap: 325 mg [scored] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Q-Pap Extra Strength: 500 mg [scored] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol: 325 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Extra Strength: 500 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Valorin: 325 mg [sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Valorin Extra: 500 mg [sugar free]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, chewable, oral: 80 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [fruit flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tablet, dispersible, oral: 80 mg, 160 mg</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [bubblegum flavor] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Mapap Children's: 80 mg [grape flavor]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Jr. Meltaways: 160 mg [bubblegum flavor] [DSC]</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Tylenol Jr. Meltaways: 160 mg [grape flavor] [DSC]</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129278\" class=\"block geq drugH1Div\"><span class=\"drugH1\">Generic Equivalent Available (US)</span>\n    <p style=\"text-indent:0em;display:inline\">Yes: Excludes extended release products; injectable formulation</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F49212230\" class=\"block prod-avail drugH1Div\"><span class=\"drugH1\">Product Availability</span>\n    <p style=\"text-indent:0em;display:inline\">Ofirmev 100 mL IV bag formulation: FDA approved November 2016; availability anticipated in the second quarter of 2017.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129297\" class=\"block adm drugH1Div\"><span class=\"drugH1\">Administration</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Oral: May administer without regard to food; may administer with food to decrease possible GI upset; shake drops and suspension well before use; do not crush or chew extended release products</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: For IV infusion only. Administer undiluted over 15 minutes.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">For doses &lt;1,000 mg (&lt;50 kg): Withdraw appropriate dose and place into separate empty, sterile container (eg, glass bottle, plastic IV container, syringe) for administration. Small volume pediatric doses (up to 600 mg [60 mL]) may be placed in a syringe and infused via syringe pump.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">For 1,000 mg doses (&ge;50 kg): Insert a vented IV set through vial stopper or a non-vented IV set through the administration spike port of the bag.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Rectal: Remove wrapper; insert suppository well up into the rectum.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129296\" class=\"block use drugH1Div\"><span class=\"drugH1\">Use</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Pain:</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Injection: Management of mild to moderate pain in patients &ge;2 years of age; management of moderate to severe pain when combined with opioid analgesia in patients &ge;2 years</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Oral, Rectal: Temporary relief of minor aches, pains, and headache</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Fever:</b> Temporary reduction of fever</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129376\" class=\"block mst drugH1Div\"><span class=\"drugH1\">Medication Safety Issues</span>\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Sound-alike/look-alike issues: </span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acephen may be confused with AcipHex</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Acetaminophen may be confused with acetazolamide</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">FeverALL may be confused with Fiberall </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Triaminic Children's Fever Reducer Pain Reliever may be confused with Triaminic cough and cold products</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Tylenol may be confused with atenolol, timolol, Tylenol PM, Tylox</p>\n        <p style=\"text-indent:-2em;margin-left:4em;margin-top:2em;text-align:justify;\">Infusion bottles of ropivacaine and IV acetaminophen look similar. Potentially fatal mix-ups have been reported in which a glass bottle of Naropin was mistaken for Ofirmev in perioperative areas.</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">Other safety concerns:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;\">Duplicate therapy issues: This product contains acetaminophen, which may be a component of combination products. Do not exceed the maximum recommended daily dose of acetaminophen.</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Infant concentration change: All children&rsquo;s and infant acetaminophen products are available as 160 mg/5 mL. Some remaining infant concentrated solutions of 80 mg/0.8 mL and 100 mg/mL may still be available on pharmacy shelves or in patient homes. Check concentrations closely prior to administering or dispensing and verify concentration available to patients prior to recommending a dose (November 2011).</p>\n        <p style=\"text-indent:-2em;margin-left:4em;\">Injection: Reports of 10-fold overdose errors using the parenteral product have occurred in the U.S. and Europe; calculation of doses in &quot;mg&quot; and subsequent administration of the dose in &quot;mL&quot; using the commercially available concentration of 10 mg/mL contributed to these errors. Expressing doses as mg <b>and</b> mL, as well as pharmacy preparation of doses,  may decrease error potential (Dart, 2012; ISMP, 2012).</p></div>\r\n</div>\r\n\n    <div class=\"collapsible\">\n      <span class=\"collapsible-title\">International issues:</span>\n      <div class=\"collapsible-wrap\">\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Depon [Greece] may be confused with Depen brand name for penicillamine [US]; Depin brand name for  nifedipine [India]; Dipen brand name for diltiazem [Greece]</p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Duorol [Spain] may be confused with Diuril brand name for chlorothiazide [US, Canada] </p>\n        <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Paralen [Czech Republic] may be confused with Aralen brand name for chloroquine [US, Mexico]</p></div>\r\n</div>\r\n</div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129285\" class=\"block adr drugH1Div\"><span class=\"drugH1\">Adverse Reactions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>Oral, Rectal:</b> Frequency not defined:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Dermatologic: Skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Endocrine &amp; metabolic: Decreased serum bicarbonate, decreased serum calcium, decreased serum sodium, hyperchloremia, hyperuricemia, increased serum glucose</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Genitourinary: Nephrotoxicity (with chronic overdose)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hematologic &amp; oncologic: Anemia, leukopenia, neutropenia, pancytopenia</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hepatic: Increased serum alkaline phosphatase, increased serum bilirubin</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Hypersensitivity: Hypersensitivity reaction (rare)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">Renal: Hyperammonemia, renal disease (analgesic)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>IV: </b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">&gt;10%: Gastrointestinal: Nausea (adults: 34%; neonates, infants, children, and adolescents: &ge;5%), vomiting (adults: 15%; neonates, infants, children, and adolescents: &ge;5%)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;\">1% to 10%:</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Cardiovascular: Hypertension (&ge;1%), hypotension (&ge;1%), peripheral edema (adults: &ge;1%), tachycardia</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Central nervous system: Headache (adults: 10%; neonates, infants, children, and adolescents: &ge;1%), insomnia (adults: 7%), agitation (neonates, infants, children, and adolescents: &ge;1%), anxiety (adults: &ge;1%), fatigue (adults: &ge;1%), trismus (adults: &ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Dermatologic: Pruritus (neonates, infants, children, and adolescents: &ge;5%), skin rash</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Endocrine &amp; metabolic: Hypoalbuminemia (neonates, infants, children, and adolescents: &ge;1%), hypokalemia (&ge;1%), hypomagnesemia (neonates, infants, children, and adolescents: &ge;1%), hypophosphatemia (neonates, infants, children, and adolescents: &ge;1%), hypervolemia</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Gastrointestinal: Constipation (neonates, infants, children, and adolescents: &ge;5%), diarrhea (neonates, infants, children, and adolescents: &ge;1%), abdominal pain</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Genitourinary: Oliguria (neonates, infants, children, and adolescents: &ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hematologic &amp; oncologic: Anemia (&ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Hepatic: Increased serum transaminases</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Local: Pain at injection site (&ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Neuromuscular &amp; skeletal: Limb pain, muscle spasm (&ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Ophthalmic: Periorbital edema</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Respiratory: Abnormal breath sounds (adults: &ge;1%), atelectasis (neonates, infants, children, and adolescents: &ge;1%), dyspnea (adults: &ge;1%), hypoxia, pleural effusion (neonates, infants, children, and adolescents: &ge;1%), pulmonary edema (neonates, infants, children, and adolescents: &ge;1%), stridor (adults: &ge;1%), wheezing (adults: &ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:6em;\">Miscellaneous: Fever (neonates, infants, children, and adolescents: &ge;1%)</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">\n      <b>All formulations:</b> &lt;1%, postmarketing, and/or case reports: Anaphylaxis, hypersensitivity reaction</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129300\" class=\"block coi drugH1Div\"><span class=\"drugH1\">Contraindications</span>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Injection: Hypersensitivity to acetaminophen or any component of the formulation; severe hepatic impairment or severe active liver disease</p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">OTC labeling: When used for self-medication, do not use with other drug products containing acetaminophen or if allergic to acetaminophen or any of the inactive ingredients</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129282\" class=\"block war drugH1Div\"><span class=\"drugH1\">Warnings/Precautions</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Concerns related to adverse effects:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatotoxicity: Injection:<b> [US Boxed Warning]. Acetaminophen has been associated with acute liver failure, at times resulting in liver transplant and death. Hepatotoxicity is usually associated with excessive acetaminophen intake and often involves more than one product that contains acetaminophen.</b> Do not exceed the maximum recommended daily dose (&gt;4 g daily in adults). In addition, chronic daily dosing may also result in liver damage in some patients.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypersensitivity/anaphylactic reactions: Hypersensitivity and anaphylactic reactions have been reported; discontinue immediately if symptoms of allergic or hypersensitivity reactions occur.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Skin reactions: Serious and potentially fatal skin reactions, including  acute generalized exanthematous pustulosis (AGEP), Stevens-Johnson syndrome (SJS), and toxic epidermal necrolysis (TEN) have occurred rarely with acetaminophen use. Discontinue therapy at the first appearance of  skin rash.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Disease-related concerns:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Ethanol use: Use with caution in patients with alcoholic liver disease; consuming &ge;3 alcoholic drinks/day may increase the risk of liver damage.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; G6PD deficiency: Use with caution in patients with known G6PD deficiency.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hepatic impairment: Use with caution in patients with hepatic impairment or active liver disease; use of the IV formulation is contraindicated in patients with severe hepatic impairment or severe active liver disease.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Hypovolemia: Use the IV formulation with caution in patients with severe hypovolemia (eg, due to dehydration or blood loss).</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Malnutrition: Use with caution in patients with chronic malnutrition.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Renal impairment: Use with caution in patients with severe renal impairment; consider dosing adjustments.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Dosage form specific issues:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Aspartame: Some products may contain aspartame, which is metabolized to phenylalanine and must be avoided (or used with caution) in patients with phenylketonuria.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Benzyl alcohol and derivatives: Some dosage forms may contain benzyl alcohol and/or sodium benzoate/benzoic acid; benzoic acid (benzoate) is a metabolite of benzyl alcohol;  large amounts of benzyl alcohol (&ge;99 mg/kg/day) have been associated with a potentially fatal toxicity (&ldquo;gasping syndrome&rdquo;) in neonates; the &ldquo;gasping syndrome&rdquo; consists of metabolic acidosis, respiratory distress, gasping respirations, CNS dysfunction (including convulsions, intracranial hemorrhage), hypotension and cardiovascular collapse (AAP [&quot;Inactive&quot; 1997]; CDC 1982); some data suggests that benzoate displaces bilirubin from protein binding sites (Ahlfors 2001); avoid or use dosage forms containing benzyl alcohol and/or benzyl alcohol derivative with caution in neonates.  See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Injection: <b>[US Boxed Warning]: Take care to avoid dosing errors; ensure that the dose in mg is not confused with mL, dosing in patients &lt;50 kg is based on body weight, infusion pumps are properly programmed, and total daily dose of acetaminophen from all sources does not exceed the maximum daily limits.</b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Polysorbate 80: Some dosage forms may contain polysorbate 80 (also known as Tweens). Hypersensitivity reactions, usually a delayed reaction, have been reported following exposure to pharmaceutical products containing polysorbate 80 in certain individuals (Isaksson, 2002; Lucente 2000; Shelley, 1995). Thrombocytopenia, ascites, pulmonary deterioration, and renal and hepatic failure have been reported in premature neonates after receiving parenteral products containing polysorbate 80 (Alade, 1986; CDC, 1984). See manufacturer&rsquo;s labeling.</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Propylene glycol: Some dosage forms may contain propylene glycol; large amounts are potentially toxic and have been associated hyperosmolality, lactic acidosis, seizures and respiratory depression; use caution (AAP [&quot;Inactive&quot; 1997]; Zar, 2007).</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>\n        <i>Other warnings/precautions:</i></b></p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Dosage limit: Limit acetaminophen dose from all sources (prescription, OTC, combination products) and all routes of administration (IV, oral, rectal) to &lt;4 g/day (adults). </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">&bull; Self-medication (OTC use): When used for self-medication, patients should be instructed to contact health care provider if symptoms get worse or new symptoms appear, redness or swelling is present in the painful area, fever lasts &gt;3 days (all ages), or pain (excluding sore throat) lasts longer than: Adults: 10 days, Children and Adolescents: 5 days, Infants: 3 days. When treating children with sore throat, if sore throat is severe, persists for &gt;2 days, or is followed by fever, rash, headache, nausea, or vomiting, consult health care provider immediately.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129365\" class=\"block cyt drugH1Div\"><span class=\"drugH1\">Metabolism/Transport Effects</span>\n    <p style=\"text-indent:0em;display:inline\">\n      <b>Substrate</b> of CYP1A2 (minor), CYP2A6 (minor), CYP2C9 (minor), CYP2D6 (minor), CYP2E1 (minor), CYP3A4 (minor); <b>Note:</b> Assignment of Major/Minor substrate status based on clinically relevant drug interaction potential</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129287\" class=\"block dri drugH1Div\"><span class=\"drugH1\">Drug Interactions</span>\n    <br/><br/><div id=\"lexiInteractAddInfo\" class=\"lexi\">(For additional information: <a href=\"https://www.uptodate.com/drug-interactions/?search=&amp;topicId=9242&amp;source=responsive_topic\" class=\"dip\" target=\"_blank\">Launch drug interactions program</a>)</div><div id=\"lexiInteractImgB\" class=\"lexi\"><img src=\"/images/lexiComp/Lexicomp_2012_71x17.gif\" width=\"71\" height=\"17\" border=\"0\"/></div><div class=\"clear\"></div><p style=\"text-indent:-2em;margin-left:2em;\">Alcohol (Ethyl): May enhance the hepatotoxic effect of Acetaminophen.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Barbiturates: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.<b> Exceptions: </b>Amobarbital; Butabarbital; Butalbital; Methohexital; PENTobarbital; Secobarbital; Thiopental.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Busulfan: Acetaminophen may increase the serum concentration of Busulfan. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">CarBAMazepine: May increase the metabolism of Acetaminophen. This may 1) diminish the effect of acetaminophen; and 2) increase the risk of liver damage.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Cholestyramine Resin: May decrease the absorption of Acetaminophen. Effect is minimal if cholestyramine is administered 1 hour after acetaminophen.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dapsone (Topical): May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Dasatinib: Acetaminophen may enhance the hepatotoxic effect of Dasatinib. Dasatinib may increase the serum concentration of Acetaminophen. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Fosphenytoin-Phenytoin: May decrease the serum concentration of Acetaminophen. Specifically, serum concentrations of acetaminophen may be decreased (leading to decreased efficacy), but the formation of the toxic N-acetyl-p-benzoquinone imine (NAPQI) metabolite may be increased (leading to increased hepatotoxicity).<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Imatinib: Acetaminophen may enhance the hepatotoxic effect of Imatinib. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Isoniazid: May enhance the adverse/toxic effect of Acetaminophen.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">LamoTRIgine: Acetaminophen may decrease the serum concentration of LamoTRIgine. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">MetyraPONE: May increase the serum concentration of Acetaminophen. More importantly, by inhibiting the conjugative metabolism of acetaminophen, metyrapone may shift the metabolism towards the oxidative route that produces a hepatotoxic metabolite.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Mipomersen: Acetaminophen may enhance the hepatotoxic effect of Mipomersen. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Nitric Oxide: May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents. Combinations of these agents may increase the likelihood of significant methemoglobinemia. Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when nitric oxide is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Phenylephrine (Systemic): Acetaminophen may increase the serum concentration of Phenylephrine (Systemic). <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Prilocaine: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Prilocaine. Combinations of these agents may increase the likelihood of significant methemoglobinemia.  Management: Monitor patients for signs of methemoglobinemia (e.g., hypoxia, cyanosis) when prilocaine is used in combination with other agents associated with development of methemoglobinemia.  Avoid lidocaine/prilocaine in infants receiving such agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Probenecid: May increase the serum concentration of Acetaminophen. Probenecid may also limit the formation of at least one major non-toxic metabolite, possibly increasing the potential for formation of the toxic NAPQI metabolite.<i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Sodium Nitrite: Methemoglobinemia Associated Agents may enhance the adverse/toxic effect of Sodium Nitrite. Combinations of these agents may increase the likelihood of significant methemoglobinemia. <i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">SORAfenib: Acetaminophen may enhance the hepatotoxic effect of SORAfenib. SORAfenib may increase the serum concentration of Acetaminophen. <i> Risk D: Consider therapy modification</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Tetracaine (Topical): May enhance the adverse/toxic effect of Methemoglobinemia Associated Agents.<i> Risk C: Monitor therapy</i></p>\n    <p style=\"text-indent:-2em;margin-left:2em;\">Vitamin K Antagonists (eg, warfarin): Acetaminophen may enhance the anticoagulant effect of Vitamin K Antagonists. This appears most likely with daily acetaminophen doses exceeding 1.3 or 2 g/day for multiple consecutive days. <i> Risk C: Monitor therapy</i></p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129314\" class=\"block foi drugH1Div\"><span class=\"drugH1\">Food Interactions</span>\n    <p style=\"text-indent:0em;text-align:justify;display:inline\">Rate of absorption may be decreased when given with food. Management: Administer without regard to food.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F5630924\" class=\"block pri drugH1Div\"><span class=\"drugH1\">Pregnancy Implications</span>\n    <p style=\"text-indent:0em;display:inline\">Acetaminophen crosses the placenta and can be detected in cord blood, newborn serum, and urine immediately after delivery (Levy 1975; Naga Rani 1989; Wang 1997). An increased risk of teratogenic effects has not been observed following maternal use of acetaminophen during pregnancy. Prenatal constriction of the ductus arteriosus has been noted in case reports following maternal use during the third trimester (Suhag 2008; Wood 2005). The use of acetaminophen in normal doses during pregnancy is not associated with an increased risk of miscarriage or still birth; however, an increase in fetal death or spontaneous abortion may be seen following maternal overdose if treatment is delayed (Li 2003; Rebordosa 2009; Riggs 1989). Frequent maternal use of acetaminophen during pregnancy may be associated with wheezing and asthma in early childhood (Perzanowki 2010).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F11384044\" class=\"block brc drugH1Div\"><span class=\"drugH1\">Breast-Feeding Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Acetaminophen is excreted in breast milk (Notarianni 1987).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">The relative infant dose (RID) of acetaminophen is 3.98% when calculated using the highest breast milk concentration located and compared to an infant therapeutic dose of 60 mg/kg/day. In general, breastfeeding is considered acceptable when the RID is &lt;10%; when an RID is &gt;25% breastfeeding should generally be avoided (Anderson 2016; Ito 2000). Using the highest milk concentration (15.9 mcg/mL), the estimated daily infant dose via breast milk is 2.385 mg/kg/day. This milk concentration was obtained following a single maternal dose of oral acetaminophen 1,000 mg (Hurden 1980).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Following a single oral maternal dose of acetaminophen 650 mg, the half-life of acetaminophen is 1.35 to 3.5 hours in breast milk (Berlin 1980). Acetaminophen can be detected in the urine of nursing infants (Notarianni 1987). Except for a single case report of a rash (Matheson 1985), adverse reactions have generally not been observed in nursing infants (Ito 1993).</p>\n    <p style=\"text-indent:0em;margin-top:2em;\">Current guidelines note that nonopioid analgesics are preferred for the treatment of pain in breastfeeding women and acetaminophen is one of the preferred nonopioid agents (Montgomery 2012; Sachs 2013). Acetaminophen is considered compatible with breast-feeding when used in usual recommended doses (WHO 2002).</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129303\" class=\"block dic drugH1Div\"><span class=\"drugH1\">Dietary Considerations</span>\n    <p style=\"text-indent:0em;display:inline\">Some products may contain phenylalanine and/or sodium.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129291\" class=\"block mop drugH1Div\"><span class=\"drugH1\">Monitoring Parameters</span>\n    <p style=\"text-indent:0em;display:inline\"> Serum acetaminophen levels: Where acute overdose suspected and with long-term use in patients with hepatic disease; relief of pain or fever</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129281\" class=\"block pha drugH1Div\"><span class=\"drugH1\">Mechanism of Action</span>\n    <p style=\"text-indent:0em;display:inline\">Although not fully elucidated, the analgesic effects are believed to be due to activation of descending serotonergic inhibitory pathways in the CNS. Interactions with other nociceptive systems may be involved as well (Smith 2009). Antipyresis is produced from inhibition of the hypothalamic heat-regulating center.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129299\" class=\"block phk drugH1Div\"><span class=\"drugH1\">Pharmacodynamics/Kinetics</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Note: With the exception of half-life, the pharmacokinetic profile in pediatric patients (0-18 years) is similar to adult patients.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Onset of action:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Oral: &lt;1 hour</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV: Analgesia: 5 to 10 minutes; Antipyretic: Within 30 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">Peak effect: IV: Analgesic: 1 hour</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Duration:</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV, Oral: Analgesia: 4 to 6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">IV: Antipyretic: &ge;6 hours</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Absorption: Primarily absorbed in small intestine (rate of absorption dependent upon gastric emptying); minimal absorption from stomach; varies by dosage form</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Distribution: ~1 L/kg at therapeutic doses </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Protein binding: 10% to 25% at therapeutic concentrations; 8% to 43% at toxic concentrations</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Metabolism: At normal therapeutic dosages, primarily hepatic metabolism to sulfate and glucuronide conjugates, while a small amount is metabolized by CYP2E1 to a highly reactive intermediate, N-acetyl-p-benzoquinone imine (NAPQI), which is conjugated rapidly with glutathione and inactivated to nontoxic cysteine and mercapturic acid conjugates. At toxic doses (as little as 4 g daily) glutathione conjugation becomes insufficient to meet the metabolic demand causing an increase in NAPQI concentrations, which may cause hepatic cell necrosis. Oral administration is subject to first pass metabolism.</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Half-life elimination: Prolonged following toxic doses </p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Neonates: 7 hours (range: 4 to 10 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Infants: ~4 hours (range: 1 to 7 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Children: 3 hours (range: 2 to 5 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Adolescents: ~3 hours (range: 2 to 4 hours)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">Adults: ~2 hours (range: 2 to 3 hours); may be slightly prolonged in severe renal insufficiency (CrCl&lt;30 mL/minute): 2 to 5.3 hours </p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Time to peak, serum: Oral: Immediate release: 10 to 60 minutes (may be delayed in acute overdoses); IV: 15 minutes</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">Excretion: Urine (&lt;5% unchanged; 60% to 80% as glucuronide metabolites; 20% to 30% as sulphate metabolites; ~8% cysteine and mercapturic acid metabolites) </p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129302\" class=\"block fee drugH1Div\"><span class=\"drugH1\">Pricing: US</span>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Capsules</b> (Tylenol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (20): $3.60</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (30): $1.37</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Chewable</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg (24): $2.10</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Gel</b> (ElixSure Fever/Pain Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (120 mL): $4.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (473 mL): $7.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Liquid</b> (Mapap Acetaminophen Extra Str Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg/15 mL (237 mL): $4.19</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (5 mL): $1.94</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Febrol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg/5 mL (120 mL): $7.18</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Solution</b> (Ofirmev Intravenous)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">10 mg/mL (100 mL): $45.02</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (Acephen Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">120 mg (50): $30.30</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (50): $32.75</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (12): $8.48</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Adults Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (50): $33.08</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Childrens Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">120 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Infants Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suppository</b> (FeverAll Junior Strength Rectal)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (6): $4.81</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (118 mL): $2.89</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Nortemp Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (118 mL): $5.55</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (120 mL): $6.30</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Infants Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (60 mL): $8.86</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Suspension</b> (Tylenol Infants Pain+Fever Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (30 mL): $5.36</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Syrup</b> (Triaminic Fever Reducer Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">160 mg/5 mL (59 mL): $4.85</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Tylenol 8 Hour Arthritis Pain Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (100): $11.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, controlled release</b> (Tylenol 8 Hour Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">650 mg (100): $11.59</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablet, orally-disintegrating</b> (Mapap Childrens Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">80 mg (30): $2.95</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Acetaminophen Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $1.86</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $2.61</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Healthy Mama Shake That Ache Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $5.70</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Mapap Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $5.69</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Pharbetol Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $2.97</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Pharbetol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $2.25</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Tylenol Extra Strength Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">500 mg (100): $10.62</p>\n    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">\n      <b>Tablets</b> (Tylenol Oral)</p>\n    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">325 mg (100): $5.48</p>\n    <p style=\"text-indent:0em;\">\n      <b>Disclaimer: </b>A representative AWP (Average Wholesale Price) price or price range is provided as reference price only. A range is provided when more than one manufacturer's AWP price is available and uses the low and high price reported by the manufacturers to determine the range. The pricing data should be used for benchmarking purposes only, and as such should not be used alone to set or adjudicate any prices for reimbursement or purchasing functions or considered to be an exact price for a single product and/or manufacturer.  Medi-Span expressly disclaims all warranties of any kind or nature, whether express or implied, and assumes no liability with respect to accuracy of price or price range data published in its solutions.  In no event shall Medi-Span be liable for special, indirect, incidental, or consequential damages arising from use of price or price range data.  Pricing data is updated monthly.</p></div>\r\n<div xmlns=\"http://www.w3.org/1999/xhtml\" id=\"F129304\" class=\"list fbnlist drugH1Div drugBrandNames\"><span class=\"drugH1\">Brand Names: International</span>\n    <ul>\n      <li>A-Mol (TH);</li>\n      <li>Acamol (CL, IL, LI);</li>\n      <li>Acamol To-Go (IL);</li>\n      <li>Acamoli Baby (IL);</li>\n      <li>Acamoli Forte suppositories for Kids (IL);</li>\n      <li>Accelio (JP);</li>\n      <li>Acemol (VN);</li>\n      <li>ACET suppositories (SG);</li>\n      <li>Acetab (VN);</li>\n      <li>Acetalgin (CH);</li>\n      <li>Acetamol (IT);</li>\n      <li>Acicur-P (PY);</li>\n      <li>Adinol (CR, DO, GT, HN, MX, NI, SV);</li>\n      <li>Adol (EG, ET, JO, KW, LB, QA, SA);</li>\n      <li>Adolin (PA);</li>\n      <li>Adorem (CO);</li>\n      <li>Afebrin (HK);</li>\n      <li>Afebryl (LU);</li>\n      <li>Agap Fast (PL);</li>\n      <li>Agomol (TZ);</li>\n      <li>Alcocin (IN);</li>\n      <li>Alginox (EC);</li>\n      <li>Alvedon (SE);</li>\n      <li>Amadol (AU);</li>\n      <li>Ametrex (CO);</li>\n      <li>Amol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Analgiser (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Analphen (MX);</li>\n      <li>Angela (TH);</li>\n      <li>Antalgic (ZW);</li>\n      <li>Antamol (JO);</li>\n      <li>Apacet (LI);</li>\n      <li>Apap (LI);</li>\n      <li>Apimol (ZW);</li>\n      <li>Aptamol (IN);</li>\n      <li>Arfen (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, MY, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Atamel (PE);</li>\n      <li>Avadol (MY);</li>\n      <li>Axcel (MY);</li>\n      <li>Ben-U-Ron (CH, PT);</li>\n      <li>ben-u-ron (HU);</li>\n      <li>Benuron (JP);</li>\n      <li>Betamol (ZW);</li>\n      <li>Biogesic (SG);</li>\n      <li>Biogesic Suspension (HK);</li>\n      <li>Biopain (PH);</li>\n      <li>Calapol (ID);</li>\n      <li>Calonal (JP);</li>\n      <li>Calpol (AE, BF, BH, BJ, CI, CY, EG, ET, GH, GM, GN, IE, IQ, IR, JO, JP, KE, KW, LB, LK, LR, LY, MA, ML, MR, MT, MU, MW, NE, NG, OM, PR, QA, SA, SC, SD, SI, SL, SN, SY, TN, TZ, UG, YE, ZM, ZW);</li>\n      <li>Causalon (AR);</li>\n      <li>Cemol (TH);</li>\n      <li>Cetal (ET);</li>\n      <li>Cetapain (ID);</li>\n      <li>Cetapyrin (LK);</li>\n      <li>Cetta (TH);</li>\n      <li>Champ Syrup (KR);</li>\n      <li>Children's Bufferin (CN);</li>\n      <li>Children's S Tylenol (KR);</li>\n      <li>Christamol (HK);</li>\n      <li>Claradol (MA);</li>\n      <li>Cotemp (TH);</li>\n      <li>Croix Blanche (LU);</li>\n      <li>Curpol (LU);</li>\n      <li>Dafalgan (BE, LU);</li>\n      <li>Dafalgan odis (LU);</li>\n      <li>Dailyal (LV);</li>\n      <li>Daleron (HR, SI);</li>\n      <li>Den-U-Ron (CN);</li>\n      <li>Denamol (TH);</li>\n      <li>Depon (TR);</li>\n      <li>Dirox (AR);</li>\n      <li>Dismifen (MX);</li>\n      <li>Dol-Stop (LU);</li>\n      <li>Dolan Infantil (GT, HN, NI, SV);</li>\n      <li>Dolex (UY);</li>\n      <li>Dolgesic (ES);</li>\n      <li>Doliprane (FR, IN, LB, MA);</li>\n      <li>Dolitabs (FR);</li>\n      <li>Dolomol (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Dolorol (ZA);</li>\n      <li>Dolprone (LU);</li>\n      <li>Doluvital (MX);</li>\n      <li>Dolviran (MX);</li>\n      <li>Dumin (LK);</li>\n      <li>Dymadon (AU);</li>\n      <li>Eferalhan (UA);</li>\n      <li>Efermol (PY);</li>\n      <li>Efferalgan (HR, HU, LT, LU, LV);</li>\n      <li>Efferalgan 500 (CR, DO, EE, GT, HN, NI, PA, SV);</li>\n      <li>Efferalganodis (FR);</li>\n      <li>Enelfa (LU);</li>\n      <li>Eterfix (ID);</li>\n      <li>Europain (HK);</li>\n      <li>Fast (BD);</li>\n      <li>Fbridol (ET);</li>\n      <li>Febridol (AU);</li>\n      <li>Febrile Free (PH);</li>\n      <li>Fervex (BR);</li>\n      <li>Fibralgin (HR);</li>\n      <li>Filanc (MX);</li>\n      <li>Fortolin (CN, HK);</li>\n      <li>Gelocatil (ES);</li>\n      <li>Geluprane 500 (FR);</li>\n      <li>Hedex (IE);</li>\n      <li>Hoemal (MY);</li>\n      <li>Ifimol (UA);</li>\n      <li>Kelvin (ET, LK);</li>\n      <li>Lekadol (HR);</li>\n      <li>Lemgrip (BE, LU);</li>\n      <li>Lonarid mono (LU);</li>\n      <li>Lotemp (TH);</li>\n      <li>Lupocet (HR);</li>\n      <li>Maccabimol (IL);</li>\n      <li>Mafidol (PE);</li>\n      <li>Medipyrin (SK);</li>\n      <li>Mejoralito Junior (MX);</li>\n      <li>Mejoralito Pedi&aacute;trico (MX);</li>\n      <li>Meldol (ZW);</li>\n      <li>Metagesic (PH);</li>\n      <li>Mexalen (AT, CZ, HU);</li>\n      <li>Minopan (KR);</li>\n      <li>Momentum (LU);</li>\n      <li>Mypara (TH);</li>\n      <li>Napafen (EC);</li>\n      <li>Napamol (ZA);</li>\n      <li>Napaton (TW);</li>\n      <li>Napran (PH);</li>\n      <li>Naprex (ID);</li>\n      <li>NEBS (JP);</li>\n      <li>Neuridon (LU);</li>\n      <li>Nordinet Infantil (MX);</li>\n      <li>Normotemp (EC);</li>\n      <li>Novadol (ZW);</li>\n      <li>Nufadol (ID);</li>\n      <li>Omnipap (PL);</li>\n      <li>Omol (QA);</li>\n      <li>Pacemol (KR);</li>\n      <li>Padolieve (IE);</li>\n      <li>Pamol (BH, DK, JO, NZ);</li>\n      <li>Pamol 650 (SG);</li>\n      <li>Panadol (AE, AU, BE, BF, BG, BH, BJ, CH, CI, CL, CN, CY, CZ, EE, EG, ES, ET, FI, FR, GB, GH, GM, GN, GR, HK, HU, ID, IE, IL, IQ, IR, IT, JO, KE, KR, KW, LB, LK, LR, LU, LV, LY, MA, ML, MR, MT, MU, MW, NE, NG, NL, NZ, OM, PE, PK, PL, PT, QA, RO, RU, SA, SC, SD, SG, SK, SL, SN, SY, TH, TN, TW, TZ, UA, UG, YE, ZM, ZW);</li>\n      <li>Panadol Actifast (MY, SG);</li>\n      <li>Panadol Extend (SG);</li>\n      <li>Panadol for Children (SG);</li>\n      <li>Panadon (HR);</li>\n      <li>Panadrex (ET);</li>\n      <li>Panamax (AU);</li>\n      <li>Panodil (DK, NO, SE);</li>\n      <li>Para-IV (PH);</li>\n      <li>Paracet (IS, NO, ZW);</li>\n      <li>Paracetamol (HR);</li>\n      <li>Paracetamol Pharmavit (HU);</li>\n      <li>Paracetamol-ratiopharm (LU);</li>\n      <li>Paracetol (LK);</li>\n      <li>Paracip (LV);</li>\n      <li>Paragin (TH);</li>\n      <li>Paralgin (AU);</li>\n      <li>Paralief (IE);</li>\n      <li>Paramol (IL, LB, RO, TW);</li>\n      <li>Paramol Kat Drops (IL);</li>\n      <li>Parapaed (DE);</li>\n      <li>Parapaed Junior (NZ);</li>\n      <li>Parapaed Six Plus (NZ);</li>\n      <li>Paratabs (IS);</li>\n      <li>Parcemol (HK);</li>\n      <li>Parcemol Forte (HK);</li>\n      <li>Parmol (HK);</li>\n      <li>Paromon (HK);</li>\n      <li>Parvid (PH);</li>\n      <li>Paximol (SG);</li>\n      <li>Pe-Tam (LU);</li>\n      <li>Pedipan (KR);</li>\n      <li>Penral-Night (KR);</li>\n      <li>Perdolan Mono (LU);</li>\n      <li>Perfalgan (AE, AT, BG, CH, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, IE, IL, IN, IS, IT, JO, KR, KW, LB, LT, MT, NZ, PL, PT, QA, RO, RU, SA, SE, SI, SK, TR, VN, ZA);</li>\n      <li>Perfusalgan (BE);</li>\n      <li>Pharmacen-M (MX);</li>\n      <li>Pinex (NO);</li>\n      <li>Pireta (ID);</li>\n      <li>Plicet (HR);</li>\n      <li>Poro (ID, MY, PH, SG, TH);</li>\n      <li>Portem (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Progesic (HK);</li>\n      <li>Raperon (KR);</li>\n      <li>Rapidene (LK);</li>\n      <li>Rapidol (CL, UA);</li>\n      <li>Reliv (SE);</li>\n      <li>Remedol (MT, PR, TR);</li>\n      <li>Revanin (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Rhinapen elixir (KR);</li>\n      <li>Rubophen (HU);</li>\n      <li>Salzone (BF, BJ, CI, ET, GH, GM, GN, KE, LR, MA, ML, MR, MU, MW, NE, NG, SC, SD, SL, SN, TN, TZ, UG, ZM, ZW);</li>\n      <li>Sanmol (PH);</li>\n      <li>Sanmol Infusion (ID);</li>\n      <li>Saridon (CO);</li>\n      <li>Sedalito (MX);</li>\n      <li>Sedalmerck (CR, DO, GT, HN, NI, PA, SV);</li>\n      <li>Selegesic (PH);</li>\n      <li>Sensamol (IL);</li>\n      <li>Setamol (HK);</li>\n      <li>Setopain (KR);</li>\n      <li>Setopain ER (KR);</li>\n      <li>Sinebriv (PL);</li>\n      <li>Sinedol (DO, MX);</li>\n      <li>Strimol (ZW);</li>\n      <li>Supadol mono (LU);</li>\n      <li>Suspen ER (KR);</li>\n      <li>Tafirol (PE);</li>\n      <li>Tamin (TZ);</li>\n      <li>Tamoliv (ID);</li>\n      <li>Tasmen (KR);</li>\n      <li>Tempol (MY);</li>\n      <li>Tempra (ID, JP, LU, MX);</li>\n      <li>Tempte (TW);</li>\n      <li>Teramol (PH);</li>\n      <li>Teramol Forte (PH);</li>\n      <li>Tipol (IE);</li>\n      <li>Toniker (TW);</li>\n      <li>Turpan (ID);</li>\n      <li>Tylenol (BR, CH, DE, JP, KR, MX, PH, PT, TH, VE);</li>\n      <li>Tylenol 8-hour (TH);</li>\n      <li>Tylenol Acetaminophen Extended Relief (CN);</li>\n      <li>Tylenol ER (KR);</li>\n      <li>Tylenol Extra Fuerte (PY);</li>\n      <li>Tylenol Forte (AE, BH, CY, EG, IQ, IR, JO, KW, LB, LY, OM, QA, SA, SY, YE);</li>\n      <li>Tylex (BB, BM, BS, BZ, CR, DO, GT, GY, HN, JM, MX, NI, PA, SR, SV, TT);</li>\n      <li>Umbral (EC);</li>\n      <li>Winadol (CO, VE);</li>\n      <li>Xcel (BD);</li>\n      <li>Xebramol (TH);</li>\n      <li>XL-Dol Infantil (MX);</li>\n      <li>Z-Mol (PY)</li></ul></div>\r\n</div><div id=\"topicAgreement\">Use of UpToDate is subject to the <a href=\"https://www.uptodate.com/legal/license\" class=\"licenseLink\" id=\"sla_in_page\">Subscription and License Agreement</a>.</div><div id=\"references\" class=\"headingAnchor\"><h1>REFERENCES</h1><ol id=\"reference\">\r\n<li>\r\n<div class=\"reference\">\n    Acephen (acetaminophen suppositories) [prescribing information]. South Plainfield, NJ: G&amp;W Laboratories; April 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ahlfors CE. Benzyl alcohol, kernicterus, and unbound bilirubin. <i>J Pediatr</i>. 2001;139(2):317-319.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/11487763/pubmed\" target=\"_blank\" id=\"11487763\">11487763</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Alade SL, Brown RE, Paquet A. Polysorbate 80 and E-Ferol toxicity. <i>Pediatrics.</i> 1986;77(4):593-597.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/3960626/pubmed\" target=\"_blank\" id=\"3960626\">3960626</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Academy of Pediatrics Committee on Drugs, &quot;Acetaminophen Toxicity in Children,&rdquo; <i>Pediatrics</i>, 2001, 108(4):1020-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/11581462/pubmed\" target=\"_blank\" id=\"11581462\">11581462</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Geriatrics Society Panel on Pharmacological Management of Persistent Pain in Older Persons. Pharmacological management of persistent pain in older persons. <i>J Am Geriatr Soc</i>. 2009;57(8):1331-1346.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19573219/pubmed\" target=\"_blank\" id=\"19573219\">19573219</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    American Pain Society, 2008: Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain. 6th ed, Glenview, IL: American Pain Society, 2008.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anand KJ, Chair, International Evidence-Based Group for Neonatal Pain, personal correspondence, April 2002.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anand KJ, International Evidence-Based Group for Neonatal Pain. Consensus statement for the prevention and management of pain in the newborn. <i>Arch Pediatr Adolesc Med</i>. 2001;155(2):173-180.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anderson PO, Sauberan JB. Modeling drug passage into human milk. <i>Clin Pharmacol Ther</i>. 2016;100(1):42-52.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/27060684/pubmed\" target=\"_blank\" id=\"27060684\">27060684</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Anderson PO, Sauberan JB, Lane JR, et al, &ldquo;Hydrocodone Excretion Into Breast Milk: The First Two Reported Cases,&rdquo; <i>Breastfeed Med</i>, 2007, 2(1):10-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/17661614/pubmed\" target=\"_blank\" id=\"17661614\">17661614</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Aronoff GR, Bennett WM, Berns JS, et al, <i>Drug Prescribing in Renal Failure: Dosing Guidelines for Adults and Children</i>, 5th ed. Philadelphia, PA: American College of Physicians; 2007.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bagheri H, Bernhard NB, and Montastruc JL, &ldquo;Potentiation of the Acenocoumarol Anticoagulant Effect by Acetaminophen,&rdquo; <i>Ann Pharmacother</i>, 1999, 33(4):506.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10332548/pubmed\" target=\"_blank\" id=\"10332548\">10332548</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bannwarth B, P&eacute;hourcq F. Pharmacological rationale for the clinical use of paracetamol: pharmacokinetic and pharmacodynamic issues. <i>Drugs</i>. 2003;63(2):5-13.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Barker JD Jr, de Carle DJ, and Anuras S, &ldquo;Chronic Excessive Acetaminophen Use in Liver Damage,&rdquo; <i>Ann Intern Med</i>, 1977, 87(3):299-301.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/900673/pubmed\" target=\"_blank\" id=\"900673\">900673</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Barr J, Fraser GL, Puntillo K, et al, &ldquo;Clinical Practice Guidelines for the Management of Pain, Agitation, and Delirium in Adult Patients in the Intensive Care Unit,&rdquo; <i>Crit Care Med</i>, 2013, 41(1):263-306.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/23269131/pubmed\" target=\"_blank\" id=\"23269131\">23269131</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Berlin CM Jr, Yaffe SJ, Ragni M. Disposition of acetaminophen in milk, saliva, and plasma of lactating women. <i>Pediatr Pharmacol (New York)</i>. 1980;1(2):135-141.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7202185/pubmed\" target=\"_blank\" id=\"7202185\">7202185</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Birmingham PK, Tobin MJ, Fisher DM, et al, &ldquo;Initial and Subsequent Dosing of Rectal Acetaminophen in Children: A 24-Hour Pharmacokinetic Study of New Dose Recommendations,&rdquo; <i>Anesthesiology</i>, 2001, 94(3):385-9.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/11374595/pubmed\" target=\"_blank\" id=\"11374595\">11374595</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bosilkovska M, Walder B, Besson M, Daali Y, Desmeules J. Analgesics in patients with hepatic impairment: pharmacology and clinical implications. <i>Drugs</i>. 2012;72(12):1645-1669.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/22867045/pubmed\" target=\"_blank\" id=\"22867045\">22867045</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Brackett CC and Bloch JD, &ldquo;Phenytoin as a Possible Cause of Acetaminophen Hepatotoxicity: Case Report and Review of the Literature,&rdquo; <i>Pharmacotherapy</i>, 2000, 20(2):229-33.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10678302/pubmed\" target=\"_blank\" id=\"10678302\">10678302</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Bradley JD, Brandt KD, Katz BP, et al, &ldquo;Comparison of an Antiinflammatory Dose of Ibuprofen, an Analgesic Dose of Ibuprofen, and Acetaminophen in the Treatment of Patients With Osteoarthritis of the Knee,&rdquo; <i>N Engl J Med</i>, 1991, 325(2):87-91.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/2052056/pubmed\" target=\"_blank\" id=\"2052056\">2052056</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Buck ML, &ldquo;Perioperative Use of High-Dose Rectal Acetaminophen,&rdquo; Pediatr Pharmacol (New York), 2001, 7(9). Available at http://www.medscape.com/viewarticle/415082_2</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Burkhart KK, Janco N, Kulig KW, et al, &ldquo;Cimetidine as Adjunctive Treatment for Acetaminophen Overdose,&rdquo; <i>Hum Exp Toxicol</i>, 1995, 14(3):299-304.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7779462/pubmed\" target=\"_blank\" id=\"7779462\">7779462</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Butler JM, Begg EJ. Free drug metabolic clearance in elderly people. <i>Clin Pharmacokinet</i>. 2008;47(5):297-321.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/18399712/pubmed\" target=\"_blank\" id=\"18399712\">18399712</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Caldeira D, Costa J, Barra M, Pinto FJ, Ferreira JJ. How safe is acetaminophen use in patients treated with vitamin K antagonists? A systematic review and meta-analysis. <i>Thromb Res.</i> 2015; 135(1):58-61.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/25456003/pubmed\" target=\"_blank\" id=\"25456003\">25456003</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Neonatal deaths associated with use of benzyl alcohol&mdash;United States. <i>MMWR Morb Mortal Wkly Rep</i>. 1982;31(22):290-291. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00001109.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/6810084/pubmed\" target=\"_blank\" id=\"6810084\">6810084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Centers for Disease Control (CDC). Unusual syndrome with fatalities among premature infants: association with a new intravenous vitamin E product.<i> MMWR Morb Mortal Wkly Rep</i>. 1984;33(14):198-199. <a href=\"http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm\" target=\"_blank\">http://www.cdc.gov/mmwr/preview/mmwrhtml/00000319.htm</a><span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/6423951/pubmed\" target=\"_blank\" id=\"6423951\">6423951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Chandok N, Watt KD. Pain management in the cirrhotic patient: the clinical challenge. <i>Mayo Clin Proc</i>. 2010;85(5):451-458.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/20357277/pubmed\" target=\"_blank\" id=\"20357277\">20357277</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Clissold SP, &ldquo;Paracetamol and Phenacetin,&rdquo; <i>Drugs</i>, 1986, 32(Suppl 4):46-59.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/3552585/pubmed\" target=\"_blank\" id=\"3552585\">3552585</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dart RC and Rumack BH, &ldquo;Intravenous Acetaminophen in the United States: Iatrogenic Dosing Errors,&rdquo; <i>Pediatrics</i>, 2012, 129(2):349-53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/22271694/pubmed\" target=\"_blank\" id=\"22271694\">22271694</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dionne RA, Campbell RA, Cooper SA, et al, &ldquo;Suppression of Postoperative Pain by Preoperative Administration of Ibuprofen in Comparison to Placebo, Acetaminophen, and Acetaminophen Plus Codeine,&rdquo; <i>J Clin Pharmacol</i>, 1983, 23(1):37-43.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/6341415/pubmed\" target=\"_blank\" id=\"6341415\">6341415</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &ldquo;Drugs for Pain,&rdquo; <i>Med Lett Drugs Ther</i>, 2000, 42(1085):73-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10951654/pubmed\" target=\"_blank\" id=\"10951654\">10951654</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Duggan ST and Scott LJ, &ldquo;Intravenous Paracetamol (Acetaminophen),&rdquo; <i>Drugs</i>, 2009, 69(1):101-13.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19192939/pubmed\" target=\"_blank\" id=\"19192939\">19192939</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Dwyer JP, Jayasekera C, Nicoll A. Analgesia for the cirrhotic patient: a literature review and recommendations. <i>J Gastroenterol Hepatol</i>. 2014;29(7):1356-1360.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/24548074/pubmed\" target=\"_blank\" id=\"24548074\">24548074</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    FDA Drug Safety Communication: Prescription acetaminophen products to be limited to 325 mg per dosage unit; boxed warning will highlight potential for severe liver failure. From: <a href=\"https://www.fda.gov/Drugs/DrugSafety/ucm239821.htm\" target=\"_blank\">https://www.fda.gov/Drugs/DrugSafety/ucm239821.htm</a>. Accessed: 9/29/17.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Feverall (acetaminophen) [prescribing information]. Cranford, NJ: Actavis; received August 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Feverall Children's (acetaminophen) [prescribing information]. Cranford, NJ: Actavis; received August 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Feverall Infant's (acetaminophen) [prescribing information]. Cranford, NJ: Actavis; received August 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Feverall Junior Strength (acetaminophen) [prescribing information]. Cranford, NJ: Actavis; received August 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Fitzcharles MA, Lussier D, Shir Y. Management of chronic arthritis pain in the elderly. <i>Drugs Aging</i>. 2010;27(6):471-490.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/20524707/pubmed\" target=\"_blank\" id=\"20524707\">20524707</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gadisseur AP, Van Der Meer FJ, and Rosendaal FR, &ldquo;Sustained Intake of Paracetamol (Acetaminophen) During Oral Anticoagulant Therapy With Coumarins Does Not Cause Clinically Important INR Changes: A Randomized Double-Blind Clinical Trial,&rdquo; <i>J Thromb Haemost</i>, 2003, 1(4):714-7.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/12871405/pubmed\" target=\"_blank\" id=\"12871405\">12871405</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Gebauer MG, Nyfort-Hansen K, Henschke PJ, et al, &ldquo;Warfarin and Acetaminophen Interaction,&rdquo; <i>Pharmacotherapy</i>, 2003, 23(1):109-12.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/12523469/pubmed\" target=\"_blank\" id=\"12523469\">12523469</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Harrison PM, Keays R, Bray GP, et al, &ldquo;Improved Outcome of Paracetamol-Induced Fulminant Hepatic Failure by Late Administration of Acetylcysteine,&rdquo; <i>Lancet</i>, 1990, 335(8705):1572-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/1972496/pubmed\" target=\"_blank\" id=\"1972496\">1972496</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hayward KL, Powell EE, Irvine KM, Martin JH. Can paracetamol (acetaminophen) be administered to patients with liver impairment? <i>Br J Clin Pharmacol</i>. 2016;81(2):210-222.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/26460177/pubmed\" target=\"_blank\" id=\"26460177\">26460177</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hochberg MC, Altman RD, April KT, et al, &ldquo;American College of Rheumatology 2012 Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip, and Knee,&rdquo; <i>Arthritis Care Res (Hoboken)</i>, 2012, 64(4):465-74.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/22563589/pubmed\" target=\"_blank\" id=\"22563589\">22563589</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hurden EL, Harvey DL, Lewis PJ. Excretion of paracetamol in human breast milk, Neonatal Society Meeting Held on 4 July 1980 in Southampton. <i>Arch Dis Child. </i>1980; 55(12):969-972.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/21032602/pubmed\" target=\"_blank\" id=\"21032602\">21032602</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Hylek EM, Heiman H, Skates SJ, et al, &ldquo;Acetaminophen and Other Risk Factors for Excessive Warfarin Anticoagulation,&rdquo; <i>JAMA</i>, 1998, 279(9):657-62.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/9496982/pubmed\" target=\"_blank\" id=\"9496982\">9496982</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Imani F, Motavaf M, Safari S, Alavian SM. The therapeutic use of analgesics in patients with liver cirrhosis: a literature review and evidence-based recommendations. <i>Hepat Mon</i>. 2014;14(10):e23539.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/25477978/pubmed\" target=\"_blank\" id=\"25477978\">25477978</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &quot;Inactive&quot; ingredients in pharmaceutical products: update (subject review). American Academy of Pediatrics (AAP) Committee on Drugs. <i>Pediatrics</i>. 1997;99(2):268-278.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/9024461/pubmed\" target=\"_blank\" id=\"9024461\">9024461</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Isaksson M, Jansson L. Contact allergy to Tween 80 in an inhalation suspension. <i>Contact Dermatiti</i>s. 2002;47(5):312-313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/12534540/pubmed\" target=\"_blank\" id=\"12534540\">12534540</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Institute for Safe Medication Practices (ISMP), &ldquo;IV Acetaminophen and Overdoses in Kids,&rdquo; ISMP Medication Safety Alert, April 19, 2012. Available at http://ismp.org/Newsletters/acutecare/issue.asp?dt=20120419 </div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ito S, Blajchman A, Stephenson M, Eliopoulos C, Koren G. Prospective follow-up of adverse reactions in breast-fed infants exposed to maternal medication. <i>Am J Obstet Gynecol</i>. 1993;168(5):1393-1399.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/8498418/pubmed\" target=\"_blank\" id=\"8498418\">8498418</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ito S. Drug therapy for breast-feeding women. <i>N Engl J Med</i>. 2000;343(2):118-126.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10891521/pubmed\" target=\"_blank\" id=\"10891521\">10891521</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Katzir Z, Baruch O, Hochman B, et al, &ldquo;Spontaneous Remission of Paracetamol Induced Acute Renal Failure,&rdquo; <i>Clin Nephrol</i>, 1995, 43(5):346.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7634553/pubmed\" target=\"_blank\" id=\"7634553\">7634553</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kliegman RM, Stanton BF, St. Gemell JW, et al, eds. Nelson Textbook of Pediatrics. 19th ed. Philadelphia, PA: Saunders Elsevier; 2011.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Knoop KJ, Snook CP, Stephan M, et al, &ldquo;Failure of N-Acetylcysteine (NAC) to Prevent Acetaminophen-Induced Renal Failure,&rdquo; <i>Vet Hum Toxicol</i>, 1993, 35:336.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kwan D, Bartle WR, and Walker SE, &quot;The Effects of Acetaminophen on Pharmacokinetics and Pharmacodynamics of Warfarin,&quot; <i>J Clin Pharmacol</i>, 1999, 39(1):68-75.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/9987702 /pubmed\" target=\"_blank\" id=\"9987702 \">9987702 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Kwan D, Bartle WR, and Walker SE, &ldquo;The Effects of Acute and Chronic Acetaminophen Dosing on the Pharmacodynamics and Pharmacokinetics of (R)- and (S)-Warfarin,&rdquo; <i>Clin Pharmacol Ther</i>, 1995, 57:212.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lee WM, &ldquo;Drug-Induced Hepatotoxicity,&rdquo; <i>N Engl J Med</i>, 1995, 333(17):1118-27.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7565951/pubmed\" target=\"_blank\" id=\"7565951\">7565951</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Levy G, Garrettson LK, and Soda DM, Letter: evidence of placental transfer of acetaminophen. <i>Pediatrics</i>. 1975, 55(6):895.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/1134892/pubmed\" target=\"_blank\" id=\"1134892\">1134892</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Li DK, Liu L, Odouli R. &quot;Exposure to non-steroidal anti-inflammatory drugs during pregnancy and risk of miscarriage: population based cohort study. <i>BMJ</i>. 2003, 327(7411):368.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/12919986/pubmed\" target=\"_blank\" id=\"12919986\">12919986</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Licht H, Seeff LB, and Zimmerman HJ, &ldquo;Apparent Potentiation of Acetaminophen Hepatotoxicity by Alcohol,&rdquo; <i>Ann Intern Med</i>, 1980, 92(4):511.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Liukas A, Kuusniemi K, Aantaa R, et al. Pharmacokinetics of intravenous paracetamol in elderly patients. <i>Clin Pharmacokinet</i>. 2011;50(2):121-129.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/21241071/pubmed\" target=\"_blank\" id=\"21241071\">21241071</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Lucente P, Iorizzo M, Pazzaglia M. Contact sensitivity to Tween 80 in a child. <i>Contact Dermatitis</i>. 2000;43(3):172.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10985636/pubmed\" target=\"_blank\" id=\"10985636\">10985636</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Makris UE, Abrams RC, Gurland B, Reid MC. Management of persistent pain in the older patient: a clinical review. <i>JAMA</i>. 2014;312(8):825-836.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/25157726/pubmed\" target=\"_blank\" id=\"25157726\">25157726</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mapap Children's (acetaminophen) [prescribing information]. Livonia, MI: Major Pharmaceuticals; October 2015.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Matheson I, Lunde PK, Notarianni L. Infant rash caused by paracetamol in breast milk? <i>Pediatrics</i>. 1985, 76(4):651-652.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/2931668/pubmed\" target=\"_blank\" id=\"2931668\">2931668</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mayoral CE, Marino RV, Rosenfeld W, et al, &ldquo;Alternating Antipyretics: Is This an Alternative?&rdquo; <i>Pediatrics</i>, 2000, 105(5):1009-12.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10790455/pubmed\" target=\"_blank\" id=\"10790455\">10790455</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    McClain CJ, Kromhout JP, Peterson FJ, et al, &ldquo;Potentiation of Acetaminophen Hepatotoxicity by Alcohol,&rdquo; <i>JAMA</i>, 1980, 244(3):251-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7382090/pubmed\" target=\"_blank\" id=\"7382090\">7382090</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    McLachlan AJ, Bath S, Naganathan V, et al. Clinical pharmacology of analgesic medicines in older people: impact of frailty and cognitive impairment. <i>Br J Clin Pharmacol</i>. 2011;71(3):351-364.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    McNeil Consumer Healthcare website. Frequently Asked Questions About New Dosing for Extra Strength Tylenol Products. http://www.tylenolprofessional.com/assets/v4/faqs-new-dosing.pdf. Published 2011. Accessed May 6, 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Mehlisch DR, Aspley S, Daniels SE, et al, &quot;Comparison of the Analgesic Efficacy of Concurrent Ibuprofen and Paracetamol With Ibuprofen or Paracetamol Alone in the Management of Moderate to Severe Acute Postoperative Dental Pain in Adolescents and Adults: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Single-Dose, Two-Center, Modified Factorial Study,&quot; <i>Clin Ther</i>, 2010, 32(5):882-95.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/20685496/pubmed\" target=\"_blank\" id=\"20685496\">20685496</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Montgomery A, Hale TW, Academy Of Breastfeeding Medicine. ABM clinical protocol #15: analgesia and anesthesia for the breastfeeding mother, revised 2012. <i>Breastfeed Med</i>. 2012;7(6):547-553.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/23215911/pubmed\" target=\"_blank\" id=\"23215911\">23215911</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Naga Rani MA, Joseph T, Narayanan R. Placental transfer of paracetamol. <i>J Indian Med Assoc</i>. 1989, 87(8):182-183.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/2621359/pubmed\" target=\"_blank\" id=\"2621359\">2621359</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Notarianni LJ, Oldham HG, Bennett PN. Passage of paracetamol into breast milk and its subsequent metabolism by the neonate. <i>Br J Clin Pharmacol</i>. 1987, 24(1):63-67.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/3620287/pubmed\" target=\"_blank\" id=\"3620287\">3620287</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Ofirmev (acetaminophen) [prescribing information]. Hazelwood, MO: Mallinckrodt; January 2017.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Perzanowski MS, Miller RL, Tang D, et al. Prenatal acetaminophen exposure and risk of wheeze at age 5 years in an urban low-income cohort. <i>Thorax</i>. 2010, 65(2):118-23.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19850963/pubmed\" target=\"_blank\" id=\"19850963\">19850963</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    &ldquo;Principles of Analgesic Use in the Treatment of Acute Pain and Cancer Pain,&rdquo; 6th ed, Glenview, IL: American Pain Society, 2008.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rastogi R, Meek BD. Management of chronic pain in elderly, frail patients: finding a suitable, personalized method of control. <i>Clin Interv Aging</i>. 2013;8:37-46.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/23355774/pubmed\" target=\"_blank\" id=\"23355774\">23355774</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rathmell JP, Viscomi CM, and Ashburn MA, &ldquo;Management of Nonobstetric Pain During Pregnancy and Lactation,&rdquo; <i>Anesth Analg</i>, 1997, 85(5):1074-87.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/9356103/pubmed\" target=\"_blank\" id=\"9356103\">9356103</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rebordosa C, Kogevinas M, Bech BH, et al. Use of acetaminophen during pregnancy and risk of adverse pregnancy outcomes. <i>Int J Epidemiol</i>. 2009, 38(3):706-14.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19332503/pubmed\" target=\"_blank\" id=\"19332503\">19332503</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Riggs BS, Bronstein AC, Kulig K, et al. Acute acetaminophen overdose during pregnancy. <i>Obstet Gynecol</i>. 1989, 74(2):247-53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/2748061/pubmed\" target=\"_blank\" id=\"2748061\">2748061</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Rose SR, &ldquo;Subtleties of Managing Acetaminophen Poisoning,&rdquo; <i>Am J Hosp Pharm</i>, 1994, 51(24):3065-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7856628/pubmed\" target=\"_blank\" id=\"7856628\">7856628</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sachs HC, Committee On Drugs. The transfer of drugs and therapeutics into human breast milk: an update on selected topics. <i>Pediatrics</i>. 2013;132(3):e796-809.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/23979084/pubmed\" target=\"_blank\" id=\"23979084\">23979084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shehab N, Lewis CL, Streetman DD, Donn SM. Exposure to the pharmaceutical excipients benzyl alcohol and propylene glycol among critically ill neonates.<i> Pediatr Crit Care Med</i>. 2009;10(2):256-259.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19188870/pubmed\" target=\"_blank\" id=\"19188870\">19188870</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shek KL, Chan LN, and Nutescu E, &quot;Warfarin-Acetaminophen Drug Interaction Revisited,&quot; <i>Pharmacotherapy</i>, 1999, 19(10):1153-8.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/10512064 /pubmed\" target=\"_blank\" id=\"10512064 \">10512064 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Shelley WB, Talanin N, Shelley ED. Polysorbate 80 hypersensitivity. <i>Lancet</i>. 1995;345(8980):1312-1313.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7746084/pubmed\" target=\"_blank\" id=\"7746084\">7746084</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Singer AJ, Carracio TR, and Mofenson HC, &ldquo;The Temporal Profile of Increased Transaminase Levels in Patients With Acetaminophen-Induced Liver Dysfunction,&rdquo; <i>Ann Emerg Med</i>, 1995, 26(1):49-53.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7793720/pubmed\" target=\"_blank\" id=\"7793720\">7793720</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smilkstein MJ, Knapp GL, Kulig KW, et al, &ldquo;Efficacy of Oral N-Acetylcysteine in the Treatment of Acetaminophen Overdose. Analysis of the National Multicenter Study (1976 to 1985),&rdquo; <i>N Engl J Med</i>, 1988, 319(24):1557-62.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/3059186/pubmed\" target=\"_blank\" id=\"3059186\">3059186</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Smith HS. Potential analgesic mechanisms of acetaminophen. <i>Pain Physician</i>. 2009;12(1):269-280.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/19165309/pubmed\" target=\"_blank\" id=\"19165309\">19165309</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Stork CM, Rees S, Howland MA, et al, &ldquo;Pharmacokinetics of Extended Relief vs Regular Release Tylenol in a Simulated Human Overdose,&rdquo; <i>J Toxicol Clin Toxicol</i>, 1996, 34(2):157-62.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/8618248/pubmed\" target=\"_blank\" id=\"8618248\">8618248</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Suhag A, Wood DC, Bisulli G, et al. Abstracts of the 18th World Congress on Ultrasound in Obstetrics and Gynecology. August 24-28, 2008. Chicago, Illinois, USA. <i>Ultrasound Obstet Gynecol</i>. 2008, 32(3):243-466.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/18696803/pubmed\" target=\"_blank\" id=\"18696803\">18696803</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Sullivan JE, Farrar HC. Fever and antipyretic use in children. Pediatrics. 2011; 127(3): 580-587.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/21357332/pubmed\" target=\"_blank\" id=\"21357332\">21357332</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tanaka E, Yamazaki K, and Misawa S, &quot;Update: The Clinical Importance of Acetaminophen Hepatotoxicity in Nonalcoholic and Alcoholic Subjects,&quot; <i>J Clin Pharm Ther</i>, 2000, 25(5):325-32.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/11123483 /pubmed\" target=\"_blank\" id=\"11123483 \">11123483 </a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Tylenol Arthritis Pain (acetaminophen) [prescribing information]. Ft. Washington, PA: McNeil Consumer; January 2014.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    van den Bemt PM, Geven LM, Kuitert NA, et al, &ldquo;The Potential Interaction Between Oral Anticoagulants and Acetaminophen in Everyday Practice,&rdquo; <i>Pharm World Sci</i>, 2002, 24(5):201-4.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/12426965/pubmed\" target=\"_blank\" id=\"12426965\">12426965</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    van der Steeg J, Akhtar J, Burkhart K, et al, &ldquo;Initial Prothrombin Time as a Predictor of Acetaminophen-Induced Hepatotoxicity,&rdquo; <i>Clin Toxicol</i>, 1995, 33(5):508-9.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wang PH, Yang MJ, Lee WL, et al. Acetaminophen poisoning in late pregnancy. A case report. <i>J Reprod Med</i>. 1997, 42(6):367-371.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/9219126/pubmed\" target=\"_blank\" id=\"9219126\">9219126</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Watkins PB, Kaplowitz N, Slattery JT, et al, &ldquo;Aminotransferase Elevations in Healthy Adults Receiving 4 Grams of Acetaminophen Daily: A Randomized Controlled Trial,&rdquo; <i>JAMA</i>, 2006, 296(1):87-93.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/16820551/pubmed\" target=\"_blank\" id=\"16820551\">16820551</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Whitcomb DC and Block GD, &ldquo;Association of Acetaminophen Hepatotoxicity With Fasting and Ethanol Use,&rdquo; <i>JAMA</i>, 1994, 272(23):1845-50.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7990219/pubmed\" target=\"_blank\" id=\"7990219\">7990219</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Williams HJ, Ward JR, Egger MJ, et al, &ldquo;Comparison of Naproxen and Acetaminophen in a Two-Year Study of Treatment of Osteoarthritis of the Knee,&rdquo; <i>Arthritis Rheum</i>, 1993, 36(9):1196-206.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/8216413/pubmed\" target=\"_blank\" id=\"8216413\">8216413</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wood D, Shah S, Broth RE, et al. Abstracts of the 15th World Congress on Ultrasound in Obstetrics and Gynecology, 25-29 September 2005, Vancouver, Canada. <i>Ultrasound Obstet Gynecol</i>. 2005, 26(4):309-471.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/16152007/pubmed\" target=\"_blank\" id=\"16152007\">16152007</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Woo OF, Anderson IB, Kim SY, et al, &ldquo;Shorter Duration of N-Acetylcysteine (NAC) for Acute Acetaminophen Poisoning,&rdquo; <i>Clin Toxicol</i>, 1995, 33(5):508.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    World Health Organization (WHO). Breastfeeding and maternal medication, recommendations for drugs in the eleventh WHO model list of essential drugs. 2002. Available at http://www.who.int/maternal_child_adolescent/documents/55732/en/</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Wynne HA, Cope LH, Herd B, Rawlins MD, James OF, Woodhouse KW. The association of age and frailty with paracetamol conjugation in man. <i>Age Ageing</i>. 1990;19:419-424.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/2285011/pubmed\" target=\"_blank\" id=\"2285011\">2285011</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Yerman B, Tseng J, and Caravati EM, &ldquo;Pediatric Acetaminophen Ingestion: A Prospective Study of Referral Criteria,&rdquo; <i>Clin Toxicol</i>, 1995, 33(5):530.</div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zar T, Graeber C, Perazella MA. Recognition, treatment, and prevention of propylene glycol toxicity. <i>Semin Dial</i>. 2007;20(3):217-219.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/17555487/pubmed\" target=\"_blank\" id=\"17555487\">17555487</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zenger F, Russmann S, Junker E, et al, &ldquo;Decreased Glutathione in Patients With Anorexia Nervosa. Risk Factor for Toxic Liver Injury?&rdquo; <i>Eur J Clin Nutr</i>, 2004, 58(2):238-43.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/14749742/pubmed\" target=\"_blank\" id=\"14749742\">14749742</a>]</span></div>\r\n</li>\r\n<li>\r\n<div class=\"reference\">\n    Zimmerman HJ and Maddrey WC, &ldquo;Acetaminophen (Paracetamol) Hepatotoxicity With Regular Intake of Alcohol: Analysis of Instances of Therapeutic Misadventure,&rdquo; <i>Hepatology</i>, 1995, 22(3):767-3.<span class=\"pubmed-id\"> [PubMed <a href=\"https://www.uptodate.com/contents/acetaminophen-paracetamol-drug-information/abstract-text/7657281/pubmed\" target=\"_blank\" id=\"7657281\">7657281</a>]</span></div>\r\n</li></ol></div><div id=\"topicVersionRevision\">Topic 9242 Version 218.0</div></div>","outline":"<div id=\"outlineSections\"><h2>Topic Outline</h2><ul><li class=\"plainItem\"><a sectionName=\"ALERT: US Boxed Warning\" href=\"#F22782418\" class=\"outlineLink\">ALERT: US Boxed Warning</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: US\" href=\"#F129318\" class=\"outlineLink\">Brand Names: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: Canada\" href=\"#F129319\" class=\"outlineLink\">Brand Names: Canada</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacologic Category\" href=\"#F129370\" class=\"outlineLink\">Pharmacologic Category</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Adult\" href=\"#F129323\" class=\"outlineLink\">Dosing: Adult</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Pediatric\" href=\"#F129345\" class=\"outlineLink\">Dosing: Pediatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Geriatric\" href=\"#F129324\" class=\"outlineLink\">Dosing: Geriatric</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Renal Impairment\" href=\"#F129325\" class=\"outlineLink\">Dosing: Renal Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosing: Hepatic Impairment\" href=\"#F129326\" class=\"outlineLink\">Dosing: Hepatic Impairment</a></li><li class=\"plainItem\"><a sectionName=\"Dosage Forms\" href=\"#F129293\" class=\"outlineLink\">Dosage Forms</a></li><li class=\"plainItem\"><a sectionName=\"Generic Equivalent Available (US)\" href=\"#F129278\" class=\"outlineLink\">Generic Equivalent Available (US)</a></li><li class=\"plainItem\"><a sectionName=\"Product Availability\" href=\"#F49212230\" class=\"outlineLink\">Product Availability</a></li><li class=\"plainItem\"><a sectionName=\"Administration\" href=\"#F129297\" class=\"outlineLink\">Administration</a></li><li class=\"plainItem\"><a sectionName=\"Use\" href=\"#F129296\" class=\"outlineLink\">Use</a></li><li class=\"plainItem\"><a sectionName=\"Medication Safety Issues\" href=\"#F129376\" class=\"outlineLink\">Medication Safety Issues</a></li><li class=\"plainItem\"><a sectionName=\"Adverse Reactions\" href=\"#F129285\" class=\"outlineLink\">Adverse Reactions</a></li><li class=\"plainItem\"><a sectionName=\"Contraindications\" href=\"#F129300\" class=\"outlineLink\">Contraindications</a></li><li class=\"plainItem\"><a sectionName=\"Warnings/Precautions\" href=\"#F129282\" class=\"outlineLink\">Warnings/Precautions</a></li><li class=\"plainItem\"><a sectionName=\"Metabolism/Transport Effects\" href=\"#F129365\" class=\"outlineLink\">Metabolism/Transport Effects</a></li><li class=\"plainItem\"><a sectionName=\"Drug Interactions\" href=\"#F129287\" class=\"outlineLink\">Drug Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Food Interactions\" href=\"#F129314\" class=\"outlineLink\">Food Interactions</a></li><li class=\"plainItem\"><a sectionName=\"Pregnancy Implications\" href=\"#F5630924\" class=\"outlineLink\">Pregnancy Implications</a></li><li class=\"plainItem\"><a sectionName=\"Breast-Feeding Considerations\" href=\"#F11384044\" class=\"outlineLink\">Breast-Feeding Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Dietary Considerations\" href=\"#F129303\" class=\"outlineLink\">Dietary Considerations</a></li><li class=\"plainItem\"><a sectionName=\"Monitoring Parameters\" href=\"#F129291\" class=\"outlineLink\">Monitoring Parameters</a></li><li class=\"plainItem\"><a sectionName=\"Mechanism of Action\" href=\"#F129281\" class=\"outlineLink\">Mechanism of Action</a></li><li class=\"plainItem\"><a sectionName=\"Pharmacodynamics/Kinetics\" href=\"#F129299\" class=\"outlineLink\">Pharmacodynamics/Kinetics</a></li><li class=\"plainItem\"><a sectionName=\"Pricing: US\" href=\"#F129302\" class=\"outlineLink\">Pricing: US</a></li><li class=\"plainItem\"><a sectionName=\"Brand Names: International\" href=\"#F129304\" class=\"outlineLink\">Brand Names: International</a></li><li class=\"plainItem\"><a href=\"#references\">REFERENCES</a></li></ul></div><div><h2>GRAPHICS <a href=\"#\" id=\"viewAllGraphicsLink\">View All</a></h2><div id=\"outlineGraphics\"><ul><li><div id=\"DRUG_GEN/9242|TAB\" class=\"openRelatedGraphics\"><a href=\"#\" title=\"TABLES\">TABLES</a></div><ul><li><a href=\"image.htm?imageKey=DRUG/57469\" class=\"graphic graphic_table\">- Lexicomp clinical abbreviations</a></li></ul></li></ul></div></div><div><h2>RELATED TOPICS</h2><div id=\"outlineTopics\"><ul><li><a href=\"topic.htm?path=acetaminophen-paracetamol-patient-drug-information\" class=\"drug drug_patient\">Acetaminophen (paracetamol): Patient drug information</a></li><li><a href=\"topic.htm?path=acetaminophen-paracetamol-pediatric-drug-information\" class=\"drug drug_pediatric\">Acetaminophen (paracetamol): Pediatric drug information</a></li></ul></div></div>","javascript":null}